Please provide your email address to receive an email when new articles are posted on . FORT WORTH, Texas — Alcon’s ReStor multifocal IOL showed no difference in contrast sensitivity results from ...

SALT LAKE CITY, UT--(Marketwired - Jun 14, 2017) - In March 2017, the U.S. Food and Drug Administration approved a new, advanced intraocular lens implant (IOL) called the Acrysof IQ ReSTOR® +2.5 ...

Please provide your email address to receive an email when new articles are posted on . LONDON – Refractive lens exchange combined with LASIK can extend the indications for using a multifocal IOL to ...

Bossier City, La.-based Zaffater Eye Center’s Norman Zaffater, MD, became the first physician in the Shreveport-Bossier area to implant the ReSTOR Multifocal TORIC intraocular lens, according to the ...

Basel, March 23, 2017 - Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® +2.5 ...

Patients were equally satisfied with two market-leading multifocal intraocular (IOL) lenses, the Carl Zeiss Meditec AT LISA 809M and the Alcon AcrySof ReSTOR SN6AD1 IOL, each of which allowed ...

(RTTNews) - Alcon, a division of Novartis, announced it has received approval from the US FDA for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens with ACTIVEFOCUS optical design for ...

The FDA's Ophthalmic Devices Advisory Committee panel overwhelmingly recommended PMA approval of Alcon's AcrySof IQ ReSTOR Multifocal Toric Intraocular Lens for patients undergoing cataract eye ...

Novartis' ($NVS) Alcon received FDA approval for its implantable AcrySof IQ ReSTOR +2.5 Diopter intraocular lens (IOL), enabling vision correction at all distances in ...

Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens ...